Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Infectious Diseases

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/ciu135PMID 24762631PMCID PMC4017893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies.

  2014cited by this paper
• 13. Bakken JS, Borody T, Brandt LJ, et al.; Fecal Microbiota Transplantation Workgroup. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044-1049. 14. Brandt LJ, Reddy SS. Fecal microbiota transplantation for recurrent

  2014cited by this paper
• Clostridium difficile Infection in children.

  2013cited by this paper
• Duodenal infusion of donor feces for recurrent Clostridium difficile.

  2013cited by this paper
• Clostridium difficile Infection in Infants and Children

  2013cited by this paper
• Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis

  2013cited by this paper
• Fecal Transplantation for the Treatment of Recurrent Clostridium Difficile Infection

  2013cited by this paper
• Computational methods for high-throughput comparative analyses of natural microbial communities.

  2013cited by this paper
• The epidemiology of Clostridium difficile infection in children: a population-based study.

  2013cited by this paper
• Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection

  2012cited by this paper
• Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection

  2012cited by this paper
• Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients: Methodology and Results

  2012cited by this paper
• Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence.

  2012cited by this paper
• Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection.

  2012cited by this paper
• Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms

  2012cited by this paper
• Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.

  2012cited by this paper
• Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice

  2012cited by this paper
• Systematic review: faecal transplantation for the treatment of Clostridium difficile‐associated disease

  2012cited by this paper
• Fecal microbiota transplantation for recurrent clostridium difficile infection.

  2011cited by this paper
• Treating Clostridium difficile infection with fecal microbiota transplantation.

  2011cited by this paper
• Fidaxomicin versus vancomycin for Clostridium difficile infection.

  2011cited by this paper
• Risk and rewards of fecal transplants

  2011cited by this paper
• Probiotics in clostridium difficile Infection.

  2011cited by this paper
• Treatment with monoclonal antibodies against Clostridium difficile toxins.

  2010cited by this paper
• National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.

  2009cited by this paper
• Clostridium difficile infection: new developments in epidemiology and pathogenesis

  2009cited by this paper
• Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

  2008cited by this paper
• Clostridium difficile--more difficult than ever.

  2008cited by this paper
• A question of clarity: redesigning the American Association Of Blood Banks blood donor history questionnaire--a chronology and model for donor screening.

  2007cited by this paper
• Outcomes of Clostridium difficile-Associated Disease Treated With Metronidazole or Vancomycin Before and After the Emergence of NAP1/027

  2007cited by this paper
• Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.

  2006cited by this paper
• CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

  2003cited by this paper
• Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

  2003cited by this paper

• EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION IN TREATING GASTROINTESTINAL DISEASES: A SYSTEMATIC REVIEW OF EVIDENCE IN CDI, UC, IBS, AND CROHN’S DISEASE

  2025cites this paper
• Fecal microbiota transplantation restores gut microbiota diversity in children with active Crohn’s disease: a prospective trial

  2025cites this paper
• In vitro validation concept for lyophilized fecal microbiota products with a focus on bacterial viability

  2025cites this paper
• Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection : A Randomized Controlled Trial.

  2025cites this paper
• Intestinal Microbiota Modulation by Fecal Microbiota Transplantation in Nonalcoholic Fatty Liver Disease

  2025cites this paper
• Efficacy and safety of faecal microbiota transplantation (FMT) in recurrent Clostridioides difficile infection: results of a single-centre retrospective study

  2025cites this paper
• Impact of Fecal Microbiota Transplant Formulations, Storage Conditions, and Duration on Bacterial Viability, Functionality, and Clinical Outcomes in Patients with Recurrent Clostridioides difficile Infection

  2025cites this paper
• Laboratory preparation methods for human-derived fecal microbial suspensions for fecal microbiota transplantation: a review and standardization perspectives

  2025cites this paper
• Metabolic and pathogenic implications of sialic acid utilization in Clostridioides difficile infection.

  2025cites this paper
• Evaluation of the effects of different formulations of protectants on the preservation of the microbiota in fecal microbiota transplantation

  2025cites this paper
• Comparative effectiveness of different therapies for Clostridioides difficile infection in adults: a systematic review and network meta-analysis of randomized controlled trials

  2025cites this paper
• Validation methods for encapsulated faecal microbiota transplantation: a scoping review

  2025cites this paper
• Management of Recurrent Clostridioides difficile Infection (rCDI): A Systematic Literature Review to Assess the Feasibility of Indirect Treatment Comparison (ITC)

  2025influential citation
• Advances in fecal microbiota transplantation for the treatment of diabetes mellitus

  2024cites this paper
• Assessment of fecal bacterial viability and diversity in fresh and frozen fecal microbiota transplant (FMT) product in horses

  2024cites this paper
• Causal role of the gut microbiome in certain human diseases: a narrative review

  2024cites this paper
• Faecal microbial transplant

  2024cites this paper
• Biotic resistance predictably shifts microbial invasion regimes

  2024cites this paper
• Use of frozen native feces for fecal microbiota transplantation in recurrent Clostridioides difficile infection: a simple way to improve the efficiency of donor feces preparation

  2024cites this paper
• Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice

  2024cites this paper
• Should the Faecal Microbiota Composition Be Determined to Certify a Faecal Donor?

  2024cites this paper
• Corticosteroid-resistant immune-related adverse events: a systematic review

  2024cites this paper
• Fecal Microbiota Transplantation as Emerging Treatment in European Countries 2.0.

  2024cites this paper
• Microbiota and Autism: A Review on Oral and Gut Microbiome Analysis Through 16S rRNA Sequencing

  2024cites this paper
• Investigation of Freezing and Freeze-Drying for Preserving and Re-Using a Whole Microbial Cheese Community

  2024cites this paper
• Encapsulation protocol for fecal microbiota transplantation

  2024cites this paper
• Angiogenesis, a key point in the association of gut microbiota and its metabolites with disease

  2024cites this paper
• Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials

  2024cites this paper
• Effects of Different Feed Additives on Intestinal Metabolite Composition of Weaned Piglets

  2024cites this paper
• Guideline for the management of Clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024 update

  2024cites this paper
• A randomized controlled trial of efficacy and safety of Fecal Microbiota Transplant for preventing recurrent Clostridioides difficile infection.

  2024cites this paper
• Human intestinal microbiome: Role in health and disease

  2024cites this paper
• The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review

  2024cites this paper
• Exploring the complex and multifaceted interplay of the gut microbiome and cancer prevention and therapy.

  2023cites this paper
• Resolution rates in clinical trials for microbiota restoration for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis

  2023cites this paper
• Fecal transplantation for treatment of inflammatory bowel disease.

  2023cites this paper
• Controlling the human microbiome.

  2023cites this paper
• An overview of Clostridioides difficile and faecal microbiota transplant: implications for nursing practice.

  2023cites this paper
• Key determinants of success in fecal microbiota transplantation: From microbiome to clinic.

  2023cites this paper
• Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends

  2023cites this paper
• [Fecal Microbiota Transplants in the Context of (Child and Adolescent) Psychiatric Disorders].

  2023cites this paper
• Clinical response in dogs with acute hemorrhagic diarrhea syndrome following randomized probiotic treatment or fecal microbiota transplant

  2023cites this paper
• Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease

  2023cites this paper
• Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.

  2023cites this paper
• The practice of fecal microbiota transplantation in inflammatory bowel disease

  2023cites this paper
• Fecal microbiota transplantation: a novel strategy for treating Alzheimer’s disease

  2023cites this paper
• Unveiling the hidden world of gut health: Exploring cutting-edge research through visualizing randomized controlled trials on the gut microbiota

  2023cites this paper
• Co-cultivation is a powerful approach to produce a robust functionally designed synthetic consortium as a live biotherapeutic product (LBP)

  2023cites this paper
• Fecal Microbiota Transplantation in Liver Cirrhosis

  2023cites this paper
• Migraine as a Disease Associated with Dysbiosis and Possible Therapy with Fecal Microbiota Transplantation

  2023cites this paper
• Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review

  2023influential citation
• Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).

  2023cites this paper
• Multiobjective Nonlinear Model Predictive Control of the Microbial Process

  2023cites this paper
• Efficacy of washed microbiota transplantation for therapeutic targets of refractory functional constipation and the influencing factors: a single-center, retrospective, 24-week follow-up study

  2023cites this paper
• Possibilities of Autologous Fecal Microbiota Transplantation in patients with obesity and diabetes mellitus

  2022cites this paper
• Stool donor recruitment - A one-year experience.

  2022cites this paper
• Research Progress of Gut Microbiota’s Function in Metabolic and Immunological Diseases

  2022cites this paper
• Fecal Microbiota Transplant

  2022cites this paper
• The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study

  2022cites this paper
• A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis

  2022cites this paper
• Update on gut microbiota in gastrointestinal diseases

  2022cites this paper
• Gut dysbiosis and metabolic diseases.

  2022cites this paper
• The diagnostic potential and barriers of microbiome based therapeutics

  2022cites this paper
• The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota

  2022cites this paper
• Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient

  2022cites this paper
• Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection.

  2022cites this paper
• Cost-effectiveness of fecal microbiota transplantation for first recurrent Clostridioides difficile infection.

  2022cites this paper
• Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients

  2022cites this paper
• Review of fecal microbiota transplantation in autistic children and feasible techniques for fecal microbiota transplant delivery

  2022cites this paper
• Resolvin D1 Prevents Epithelial-to-Mesenchymal Transition and Reduces Collagen Deposition by Stimulating Autophagy in Intestinal Fibrosis

  2022cites this paper
• Role of prebiotic and probiotic in gastrointestinal Disease

  2022cites this paper
• Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

  2022cites this paper
• Fecal microbiota transplantation: a review on current formulations in Clostridioides difficile infection and future outlooks

  2022cites this paper
• Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application

  2022cites this paper
• Fresh Versus Frozen Stool for Fecal Microbiota Transplantation—Assessment by Multimethod Approach Combining Culturing, Flow Cytometry, and Next-Generation Sequencing

  2022cites this paper
• The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection

  2021cites this paper
• Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study

  2021cites this paper
• Future Directions in Reducing Gastrointestinal Disorders in Children With ASD Using Fecal Microbiota Transplantation

  2021cites this paper
• Stool donor recruitment - A one-year experience.

  2021cites this paper
• Management of Severe and Severe/Complicated Clostridoides difficile Infection using Sequential Fecal Microbiota Transplant by Retention Enema.

  2021cites this paper
• Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice.

  2021cites this paper
• Fecal microbiota transplantation for Crohn’s disease: a systematic review and meta-analysis

  2021cites this paper
• Towards the biogeography of prokaryotic genes

  2021cites this paper
• Pediatric Fecal Microbiota Transplantation in Recurrent Clostridioides Difficile.

  2021cites this paper
• Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls

  2021cites this paper
• Current and future applications of fecal microbiota transplantation for children

  2021cites this paper
• расстройствах Disturbances of intestinal microbiota in autism spectrum disorders: new horizons in search for pathogenetic approaches to therapy. of influence on gut-brain axis for correction of symptoms of autism spectrum disorders

  2021cites this paper
• European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.

  2021cites this paper
• Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles

  2021cites this paper
• Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?

  2021cites this paper
• Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies

  2021influential citation
• Opportunities for Nanomedicine in Clostridioides difficile Infection

  2021cites this paper
• Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.

  2021cites this paper
• Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections

  2021cites this paper
• EXPLORING THE ROLE OF THE MICROBIOTA IN DEFENCE AGAINST CLOSTRIDIOIDES DIFFICILE AND MULTIDRUG RESISTANT GRAM-NEGATIVES

  2021cites this paper
• Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT)

  2021cites this paper
• Disturbances of intestinal microbiota in autism spectrum disorders: new horizons in search for pathogenetic approaches to therapy. Рart 3. Рotential strategies of influence on gut-brain axis for correction of symptoms of autism spectrum disorders

  2021cites this paper
• Design of synthetic human gut microbiome assembly and butyrate production

  2021cites this paper
• Co-cultivation is a powerful approach to produce a robust functionally designed synthetic consortium as a live biotherapeutic product (LBP)

  2021cites this paper
• [Fecal microbiota transplantation: donor selection criteria, storage and preparation of biomaterials (review of current recommendations)].

  2021cites this paper